Overview of the current use of levosimendan in France: a prospective observational cohort study [PDF]
, 2023 Background Following the results of randomized controlled trials on levosimendan, French health authorities requested an update of the current use and side-effects of this medication on a national scale.
ARNAUD, Causeret +47 more
core +2 more sources
Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy [PDF]
, 2016 Background: The aim of this study was to determine the efficacy and safety of levosimendanin takotsubo cardiomyopathy (TC).Methods: The study was conducted in a retrospective design and 42 consecutive patients were enrolled in 6 cardiovascular centers in
Akyol, Aytac +7 more
core +2 more sources
Effect of levosimendan in experimental verapamil- induced myocardial depression [PDF]
, 2010 Background: Calcium antagonist overdose can cause severe deterioration of hemodynamics unresponsible to treatment with beta adrenergic inotropes. The aim of the study was to evaluate in an experimental model the effects of levosimendan during severe ...
Kiviniemi, Vesa +6 more
core +4 more sources
Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure [PDF]
, 2015 Background: Previous studies comparing levosimendan vs. dobutamine have revealed that levosimendan is better in relieving symptoms. Echocardiographic studies have been done using second measurements immediately following a dobutamine infusion or while it
Akturk, Ibrahim Faruk +9 more
core +2 more sources
Nanochanneled Device and Related Methods [PDF]
, 2013 A nanochannel delivery device and method of manufacturing and use. The nanochannel delivery device comprises an inlet, an outlet, and a nanochannel. The nanochannel may be oriented parallel to the primary plane of the nanochannel delivery device.
Ferrari, Mauro +7 more
core +5 more sources
Rationale, experimental data, and emerging clinical evidence on early and preventive use of levosimendan in patients with ventricular dysfunction [PDF]
, 2020 Acute ventricular dysfunction (AVD) is a complex condition with substantial morbidity and mortality, still featuring unique therapeutic challenges. Levosimendan is a calcium sensitizer and ATP-dependent potassium channel opener that was developed as an ...
Agostoni P. +5 more
core +1 more source
Use of levosimendan in acute heart failure [PDF]
, 2018 Peer ...
Giannakoulas, George +8 more
core +1 more source
The inodilator levosimendan: 20 years of experience in various settings of cardiac care [PDF]
, 2020 Levosimendan emerged in the 1990s as a first-in-class inotrope and vasodilator that enhances cardiac contractility by sensitizing the contractile response to cardiac troponin C and causes vasodilatation by opening potassium-dependent ATP channels on ...
Grossini, Elena +2 more
core +2 more sources
The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis [PDF]
, 2021 Objectives: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides a temporary support system for patients with cardiogenic shock refractory to conventional medical therapies.
Alkhulaifi, A. (Abdulaziz) +7 more
core +3 more sources
Levosimendan Administration in Limb Ischemia: Multicomponent Signaling Serving Kidney Protection [PDF]
, 2016 AIMS AND OBJECTIVES: Acute renal failure is a severe complication of lower extremity major arterial reconstructions, which could even be fatal. Levosimendan is a dual-acting positive inotropic and vasodilatory agent, which is suspected to have protective
A Morelli +50 more
core +3 more sources